Source:- business-standard.com. The Delhi High Court on Monday allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in Bayer’s cancer drug Nexavar, and rivaroxaban, the active ingredient in its blood thinner medicine Xarelto for research and development (R&D) purpose. A division Bench of Justice S Ravindra Bhat and Justice Sanjeev Sachdeva, agreeing with the majority of the findings of a